nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—Varicose vein—Varenicline—nicotine dependence	0.041	0.0423	CcSEcCtD
Fenofibrate—Coronary artery disease—Varenicline—nicotine dependence	0.0386	0.0398	CcSEcCtD
Fenofibrate—Myositis—Varenicline—nicotine dependence	0.0311	0.0321	CcSEcCtD
Fenofibrate—Peripheral vascular disorder—Varenicline—nicotine dependence	0.0311	0.0321	CcSEcCtD
Fenofibrate—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.0233	0.024	CcSEcCtD
Fenofibrate—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.0226	0.0233	CcSEcCtD
Fenofibrate—Laryngeal pain—Varenicline—nicotine dependence	0.0224	0.0231	CcSEcCtD
Fenofibrate—Acne—Varenicline—nicotine dependence	0.0181	0.0187	CcSEcCtD
Fenofibrate—Accidental injury—Varenicline—nicotine dependence	0.0173	0.0178	CcSEcCtD
Fenofibrate—Ventricular extrasystoles—Varenicline—nicotine dependence	0.0169	0.0174	CcSEcCtD
Fenofibrate—Musculoskeletal pain—Varenicline—nicotine dependence	0.0154	0.0159	CcSEcCtD
Fenofibrate—Pulmonary embolism—Varenicline—nicotine dependence	0.0153	0.0157	CcSEcCtD
Fenofibrate—Eructation—Varenicline—nicotine dependence	0.015	0.0155	CcSEcCtD
Fenofibrate—Oesophagitis—Varenicline—nicotine dependence	0.0139	0.0144	CcSEcCtD
Fenofibrate—Hypertonia—Varenicline—nicotine dependence	0.0134	0.0138	CcSEcCtD
Fenofibrate—Lymphadenopathy—Varenicline—nicotine dependence	0.013	0.0134	CcSEcCtD
Fenofibrate—Eczema—Varenicline—nicotine dependence	0.0123	0.0127	CcSEcCtD
Fenofibrate—Injury—Varenicline—nicotine dependence	0.0121	0.0124	CcSEcCtD
Fenofibrate—Renal failure acute—Varenicline—nicotine dependence	0.012	0.0124	CcSEcCtD
Fenofibrate—Libido decreased—Varenicline—nicotine dependence	0.0119	0.0123	CcSEcCtD
Fenofibrate—Increased appetite—Varenicline—nicotine dependence	0.0118	0.0122	CcSEcCtD
Fenofibrate—Atrial fibrillation—Varenicline—nicotine dependence	0.0117	0.0121	CcSEcCtD
Fenofibrate—Arthritis—Varenicline—nicotine dependence	0.0114	0.0118	CcSEcCtD
Fenofibrate—Hypoglycaemia—Varenicline—nicotine dependence	0.0114	0.0117	CcSEcCtD
Fenofibrate—Osteoarthritis—Varenicline—nicotine dependence	0.0111	0.0114	CcSEcCtD
Fenofibrate—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.011	0.0113	CcSEcCtD
Fenofibrate—Migraine—Varenicline—nicotine dependence	0.0109	0.0113	CcSEcCtD
Fenofibrate—Liver function test abnormal—Varenicline—nicotine dependence	0.0102	0.0106	CcSEcCtD
Fenofibrate—Cramp muscle—Varenicline—nicotine dependence	0.00998	0.0103	CcSEcCtD
Fenofibrate—Nasopharyngitis—Varenicline—nicotine dependence	0.00991	0.0102	CcSEcCtD
Fenofibrate—Gastritis—Varenicline—nicotine dependence	0.00981	0.0101	CcSEcCtD
Fenofibrate—Asthma—Varenicline—nicotine dependence	0.00958	0.00988	CcSEcCtD
Fenofibrate—Angina pectoris—Varenicline—nicotine dependence	0.00933	0.00962	CcSEcCtD
Fenofibrate—Bronchitis—Varenicline—nicotine dependence	0.00921	0.0095	CcSEcCtD
Fenofibrate—Pollakiuria—Varenicline—nicotine dependence	0.00885	0.00913	CcSEcCtD
Fenofibrate—Erectile dysfunction—Varenicline—nicotine dependence	0.00882	0.0091	CcSEcCtD
Fenofibrate—Photosensitivity reaction—Varenicline—nicotine dependence	0.00874	0.00902	CcSEcCtD
Fenofibrate—Weight increased—Varenicline—nicotine dependence	0.00871	0.00899	CcSEcCtD
Fenofibrate—Infestation NOS—Varenicline—nicotine dependence	0.00854	0.00881	CcSEcCtD
Fenofibrate—Infestation—Varenicline—nicotine dependence	0.00854	0.00881	CcSEcCtD
Fenofibrate—Acute coronary syndrome—Varenicline—nicotine dependence	0.00842	0.00868	CcSEcCtD
Fenofibrate—Myocardial infarction—Varenicline—nicotine dependence	0.00837	0.00864	CcSEcCtD
Fenofibrate—Conjunctivitis—Varenicline—nicotine dependence	0.0083	0.00856	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Varenicline—nicotine dependence	0.00808	0.00833	CcSEcCtD
Fenofibrate—Sinusitis—Varenicline—nicotine dependence	0.00801	0.00826	CcSEcCtD
Fenofibrate—Oedema peripheral—Varenicline—nicotine dependence	0.00755	0.00779	CcSEcCtD
Fenofibrate—Connective tissue disorder—Varenicline—nicotine dependence	0.00753	0.00777	CcSEcCtD
Fenofibrate—Visual impairment—Varenicline—nicotine dependence	0.00739	0.00762	CcSEcCtD
Fenofibrate—Eye disorder—Varenicline—nicotine dependence	0.00716	0.00739	CcSEcCtD
Fenofibrate—Cardiac disorder—Varenicline—nicotine dependence	0.00711	0.00734	CcSEcCtD
Fenofibrate—Angiopathy—Varenicline—nicotine dependence	0.00695	0.00718	CcSEcCtD
Fenofibrate—Mediastinal disorder—Varenicline—nicotine dependence	0.00691	0.00713	CcSEcCtD
Fenofibrate—Arrhythmia—Varenicline—nicotine dependence	0.00685	0.00706	CcSEcCtD
Fenofibrate—Mental disorder—Varenicline—nicotine dependence	0.00672	0.00693	CcSEcCtD
Fenofibrate—Malnutrition—Varenicline—nicotine dependence	0.00667	0.00688	CcSEcCtD
Fenofibrate—Erythema—Varenicline—nicotine dependence	0.00667	0.00688	CcSEcCtD
Fenofibrate—Flatulence—Varenicline—nicotine dependence	0.00657	0.00678	CcSEcCtD
Fenofibrate—Back pain—Varenicline—nicotine dependence	0.00645	0.00666	CcSEcCtD
Fenofibrate—Muscle spasms—Varenicline—nicotine dependence	0.00642	0.00662	CcSEcCtD
Fenofibrate—Ill-defined disorder—Varenicline—nicotine dependence	0.00619	0.00639	CcSEcCtD
Fenofibrate—Anaemia—Varenicline—nicotine dependence	0.00617	0.00636	CcSEcCtD
Fenofibrate—Malaise—Varenicline—nicotine dependence	0.00602	0.00621	CcSEcCtD
Fenofibrate—Vertigo—Varenicline—nicotine dependence	0.00599	0.00619	CcSEcCtD
Fenofibrate—Palpitations—Varenicline—nicotine dependence	0.0059	0.00608	CcSEcCtD
Fenofibrate—Cough—Varenicline—nicotine dependence	0.00582	0.00601	CcSEcCtD
Fenofibrate—Hypertension—Varenicline—nicotine dependence	0.00576	0.00594	CcSEcCtD
Fenofibrate—Arthralgia—Varenicline—nicotine dependence	0.00568	0.00586	CcSEcCtD
Fenofibrate—Myalgia—Varenicline—nicotine dependence	0.00568	0.00586	CcSEcCtD
Fenofibrate—Chest pain—Varenicline—nicotine dependence	0.00568	0.00586	CcSEcCtD
Fenofibrate—Anxiety—Varenicline—nicotine dependence	0.00566	0.00584	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00564	0.00582	CcSEcCtD
Fenofibrate—Discomfort—Varenicline—nicotine dependence	0.00561	0.00579	CcSEcCtD
Fenofibrate—Dry mouth—Varenicline—nicotine dependence	0.00556	0.00573	CcSEcCtD
Fenofibrate—Oedema—Varenicline—nicotine dependence	0.00545	0.00562	CcSEcCtD
Fenofibrate—Infection—Varenicline—nicotine dependence	0.00541	0.00558	CcSEcCtD
Fenofibrate—Nervous system disorder—Varenicline—nicotine dependence	0.00534	0.00551	CcSEcCtD
Fenofibrate—Thrombocytopenia—Varenicline—nicotine dependence	0.00533	0.0055	CcSEcCtD
Fenofibrate—Tachycardia—Varenicline—nicotine dependence	0.00531	0.00548	CcSEcCtD
Fenofibrate—Skin disorder—Varenicline—nicotine dependence	0.00529	0.00546	CcSEcCtD
Fenofibrate—Hyperhidrosis—Varenicline—nicotine dependence	0.00526	0.00543	CcSEcCtD
Fenofibrate—Anorexia—Varenicline—nicotine dependence	0.00519	0.00536	CcSEcCtD
Fenofibrate—Hypotension—Varenicline—nicotine dependence	0.00509	0.00525	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00496	0.00512	CcSEcCtD
Fenofibrate—Insomnia—Varenicline—nicotine dependence	0.00493	0.00508	CcSEcCtD
Fenofibrate—Dyspnoea—Varenicline—nicotine dependence	0.00485	0.00501	CcSEcCtD
Fenofibrate—Somnolence—Varenicline—nicotine dependence	0.00484	0.00499	CcSEcCtD
Fenofibrate—Dyspepsia—Varenicline—nicotine dependence	0.00479	0.00495	CcSEcCtD
Fenofibrate—Decreased appetite—Varenicline—nicotine dependence	0.00473	0.00488	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Varenicline—nicotine dependence	0.0047	0.00485	CcSEcCtD
Fenofibrate—Fatigue—Varenicline—nicotine dependence	0.00469	0.00484	CcSEcCtD
Fenofibrate—Pain—Varenicline—nicotine dependence	0.00466	0.0048	CcSEcCtD
Fenofibrate—Constipation—Varenicline—nicotine dependence	0.00466	0.0048	CcSEcCtD
Fenofibrate—Feeling abnormal—Varenicline—nicotine dependence	0.00449	0.00463	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Varenicline—nicotine dependence	0.00445	0.00459	CcSEcCtD
Fenofibrate—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00443	0.144	CbGpPWpGaD
Fenofibrate—Urticaria—Varenicline—nicotine dependence	0.00433	0.00446	CcSEcCtD
Fenofibrate—Body temperature increased—Varenicline—nicotine dependence	0.0043	0.00444	CcSEcCtD
Fenofibrate—Abdominal pain—Varenicline—nicotine dependence	0.0043	0.00444	CcSEcCtD
Fenofibrate—Hypersensitivity—Varenicline—nicotine dependence	0.00401	0.00414	CcSEcCtD
Fenofibrate—Asthenia—Varenicline—nicotine dependence	0.00391	0.00403	CcSEcCtD
Fenofibrate—Pruritus—Varenicline—nicotine dependence	0.00385	0.00398	CcSEcCtD
Fenofibrate—Diarrhoea—Varenicline—nicotine dependence	0.00373	0.00384	CcSEcCtD
Fenofibrate—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0036	0.117	CbGpPWpGaD
Fenofibrate—Dizziness—Varenicline—nicotine dependence	0.0036	0.00372	CcSEcCtD
Fenofibrate—Vomiting—Varenicline—nicotine dependence	0.00346	0.00357	CcSEcCtD
Fenofibrate—Rash—Varenicline—nicotine dependence	0.00343	0.00354	CcSEcCtD
Fenofibrate—Dermatitis—Varenicline—nicotine dependence	0.00343	0.00354	CcSEcCtD
Fenofibrate—Headache—Varenicline—nicotine dependence	0.00341	0.00352	CcSEcCtD
Fenofibrate—Nausea—Varenicline—nicotine dependence	0.00323	0.00334	CcSEcCtD
Fenofibrate—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00275	0.0892	CbGpPWpGaD
Fenofibrate—PPARA—Orphan transporters—GABRA4—nicotine dependence	0.00226	0.0736	CbGpPWpGaD
Fenofibrate—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00223	0.0726	CbGpPWpGaD
Fenofibrate—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00147	0.0479	CbGpPWpGaD
Fenofibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00114	0.037	CbGpPWpGaD
Fenofibrate—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00112	0.0366	CbGpPWpGaD
Fenofibrate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000928	0.0301	CbGpPWpGaD
Fenofibrate—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000924	0.03	CbGpPWpGaD
Fenofibrate—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000916	0.0298	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000855	0.0278	CbGpPWpGaD
Fenofibrate—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000752	0.0244	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—DRD2—nicotine dependence	0.000632	0.0205	CbGpPWpGaD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000612	0.0199	CbGpPWpGaD
Fenofibrate—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000604	0.0196	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000553	0.018	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000521	0.0169	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—CCAR1—nicotine dependence	0.000517	0.0168	CbGpPWpGaD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000496	0.0161	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000491	0.016	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000484	0.0157	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000424	0.0138	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.0004	0.013	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000394	0.0128	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00028	0.00908	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000263	0.00856	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00026	0.00844	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP2A7—nicotine dependence	0.000259	0.00841	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP2A7—nicotine dependence	8.39e-05	0.00273	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP2A7—nicotine dependence	6.83e-05	0.00222	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP2A7—nicotine dependence	4.51e-05	0.00146	CbGpPWpGaD
